News | January 28, 2022
Dr Reddy’s Q3FY22 PAT at Rs. 706 cr.
Dr. Reddy's Laboratories has reported consolidated financial results for the period ended December 31, 2021
Dr. Reddy's Laboratories has reported consolidated financial results for the period ended December 31, 2021
Torrent Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
The appointment is key for DefiniGEN as they expand the service portfolio to encompass compound screening
First of its kind integrated Heart Health Programme on its Health Station ‘hPod’
Oral semaglutide is a co-formulation of GLP-1RA semaglutide with an absorption enhancer SNAC which protects semaglutide from undergoing degradation in the stomach
The hospital will be operated under the name and style of Max Super Speciality Hospital, Dwarka
Industry Report highlights the opportunities and need for multiple sectoral collaboration through 12 actionable recommendations under 6 thematic areas
It provides Covid-19 detection and Omicron surveillance in less than two hours
The drug is aimed at treating Covid-19 patients with Acute Respiratory Distress Syndrome (ARDS)
Narayanan to lead SeQuent through next phase of consolidation and growth
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
